{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:47:08Z","timestamp":1769723228095,"version":"3.49.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lpm.2021.104078","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T08:03:17Z","timestamp":1634889797000},"page":"104078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Craniopharyngiomas"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-0458","authenticated-orcid":false,"given":"Ross","family":"Hamblin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsermoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-0643","authenticated-orcid":false,"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0001","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11102-008-0165-8","article-title":"Craniopharyngioma: historical notes","volume":"12","author":"Lindholm","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104078_bib0002","series-title":"Intracranial tumours: notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto","author":"Cushing","year":"1932"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-012-0402-z","article-title":"Craniopharyngioma: history","volume":"16","author":"Barkhoudarian","year":"2013","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas","volume":"27","author":"Karavitaki","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lpm.2021.104078_bib0005","series-title":"Transactions of the meeting of the American surgical association","article-title":"Remarks on the operative treatment of","author":"Halstead","year":"1910"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0006","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14310\/horm.2002.1208","article-title":"Craniopharyngiomas. Historical aspects of their management","volume":"7","author":"Roderick","year":"2008","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.lpm.2021.104078_bib0007","unstructured":"Lithgow K, P.U., Karavitaki N. Craniopharyngiomas. In: Feingold KR, Anawalt B, Boyce A, et\u00a0al., eds. Endotext [Internet]. South Dartmouth (MA): MDText.com Inc.; 2000 -2019 Mar 14."},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0008","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000121132","article-title":"Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto prefecture, Japan","volume":"25","author":"Kuratsu","year":"1996","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0009","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"89","author":"Bunin","year":"1998","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11060-011-0540-6","article-title":"Incidence of craniopharyngioma in Denmark (n\u00a0=\u00a0189) and estimated world incidence of craniopharyngioma in children and adults","volume":"104","author":"Nielsen","year":"2011","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2021.104078_bib0012","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"Zacharia","year":"2012","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0013","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3171\/jns.1995.83.2.0206","article-title":"Papillary craniopharyngioma: a clinicopathological study of 48 cases","volume":"83","author":"Crotty","year":"1995","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.lpm.2021.104078_bib0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970101002","article-title":"Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging","volume":"10","author":"Bailey","year":"1990","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0016","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00006123-199711000-00031","article-title":"Craniopharyngiomas in two consanguineous siblings: case report","volume":"41","author":"Boch","year":"1997","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s007010200058","article-title":"Craniopharyngioma in a mother and daughter","volume":"144","author":"Green","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.lpm.2021.104078_bib0018","volume":"1","author":"Cavenee","year":"2007"},{"issue":"8","key":"10.1016\/j.lpm.2021.104078_bib0019","first-page":"1427","article-title":"Craniopharyngioma: radiologic and histologic findings and recurrence","volume":"17","author":"Eldevik","year":"1996","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0020","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1097-0142(197604)37:4<1944::AID-CNCR2820370446>3.0.CO;2-#","article-title":"Craniopharyngiomas: a clinical and pathological review","volume":"37","author":"Petito","year":"1976","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0021","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1227\/00006123-199412000-00001","article-title":"Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome","volume":"35","author":"Weiner","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1016\/j.lpm.2021.104078_bib0022","doi-asserted-by":"crossref","unstructured":"Vasiljevic A., V.C., Histopathology and molecular pathology of craniopharyngioma in adults, in Adult craniopharyngiomas, R.G. Jouanneau E., Ed. 2020, Springer, Cham. p. pp 1-17.","DOI":"10.1007\/978-3-030-41176-3_1"},{"key":"10.1016\/j.lpm.2021.104078_bib0023","series-title":"Surgical pathology of the nervous system and its coverings","author":"Burger","year":"2002"},{"issue":"8-9","key":"10.1016\/j.lpm.2021.104078_bib0024","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00381-005-1190-9","article-title":"The pathogenesis of craniopharyngiomas","volume":"21","author":"Prabhu","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-012-0957-9","article-title":"Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma","volume":"124","author":"Andoniadou","year":"2012","journal-title":"Acta Neuropathol (Berl)"},{"issue":"9-10","key":"10.1016\/j.lpm.2021.104078_bib0026","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1159\/000507084","article-title":"Histopathology of parasellar neoplasms","volume":"110","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0027","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00401-014-1270-6","article-title":"BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma","volume":"127","author":"Larkin","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0028","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11102-015-0669-y","article-title":"Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells","volume":"18","author":"Marucci","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.lpm.2021.104078_bib0029","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.12688\/f1000research.11549.1","article-title":"Recent advances in molecular pathology of craniopharyngioma","volume":"6","author":"Larkin","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles","volume":"4","author":"H\u00f6lsken","year":"2016","journal-title":"Acta Neuropathologica Communications"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0032","first-page":"126","article-title":"Genomic alterations of adamantinomatous and papillary craniopharyngioma","volume":"76","author":"Goschzik","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"10.1016\/j.lpm.2021.104078_bib0033","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1210\/jc.2019-01299","article-title":"The medical therapy of craniopharyngiomas: the way ahead","volume":"104","author":"Alexandraki","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.lpm.2021.104078_bib0034","first-page":"2141","article-title":"MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma","volume":"144","author":"Haston","year":"2017","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-014-9341-8","article-title":"The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis","volume":"26","author":"Preda","year":"2015","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.lpm.2021.104078_bib0036","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnen\/nlx061","article-title":"Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma","volume":"76","author":"Donson","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0037","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-018-1830-2","article-title":"Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target","volume":"135","author":"Apps","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"issue":"8","key":"10.1016\/j.lpm.2021.104078_bib0038","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/neuonc\/noy035","article-title":"Multiplexed immunofluorescence reveals potential PD-1\/PD-L1 pathway vulnerabilities in craniopharyngioma","volume":"20","author":"Coy","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.lpm.2021.104078_bib0039","first-page":"1","article-title":"Dual BRAF\/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity","author":"Bernstein","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.lpm.2021.104078_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00791","article-title":"Targeting IL-6 Is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0041","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.2002.97.1.0003","article-title":"Craniopharyngioma in adults and children: a study of 122 surgical cases","volume":"97","author":"Van Effenterre","year":"2002","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0043","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00006123-200002000-00007","article-title":"Long-term outcomes for surgically resected craniopharyngiomas","volume":"46","author":"Duff","year":"2000","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0044","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02688699209002926","article-title":"Paediatric craniopharyngiomas: a regional review","volume":"6","author":"Graham","year":"1992","journal-title":"Br J Neurosurg"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3171\/jns.1979.50.5.0617","article-title":"Craniopharyngiomas in childhood. A rational approach to treatment","volume":"50","author":"Shapiro","year":"1979","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0046","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/neuros\/nyx570","article-title":"Adult craniopharyngioma: case series, systematic review, and meta-analysis","volume":"83","author":"Dandurand","year":"2017","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0047","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3171\/PED\/2008\/1\/2\/126","article-title":"Long-term outcome in children treated for craniopharyngioma with and without radiotherapy","volume":"1","author":"Lin","year":"2008","journal-title":"J Neurosurg Pediatr"},{"issue":"7","key":"10.1016\/j.lpm.2021.104078_bib0048","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s003810050108","article-title":"Long-term results of treatment for craniopharyngioma in children","volume":"13","author":"Villani","year":"1997","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0049","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0360-3016(99)00030-9","article-title":"The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature","volume":"44","author":"Habrand","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11060-018-2762-3","article-title":"Long-term visual outcomes of craniopharyngioma in children","volume":"137","author":"Wan","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0051","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3171\/jns.1986.65.1.0022","article-title":"Surgical management of craniopharyngiomas. A review of 74 cases","volume":"65","author":"Baskin","year":"1986","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0052","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3171\/jns.1992.76.1.0047","article-title":"Aggressive surgical management of craniopharyngiomas in children","volume":"76","author":"Hoffman","year":"1992","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0053","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.wneu.2014.10.002","article-title":"Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome","volume":"83","author":"Prieto","year":"2015","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0054","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40618-013-0050-9","article-title":"Management of craniopharyngiomas","volume":"37","author":"Karavitaki","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.lpm.2021.104078_bib0055","series-title":"Oxford textbook of endocrinology and diabetes, in imaging of the pituitary","author":"Byrne","year":"2011"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0056","first-page":"77","article-title":"MR differentiation of adamantinous and squamous-papillary craniopharyngiomas","volume":"18","author":"Sartoretti-Schefer","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2021.104078_bib0057","doi-asserted-by":"crossref","unstructured":"Buchfelder, M. and S. Schlaffer, Chapter 11 - Imaging of pituitary pathology, in Handbook of clinical neurology, E. Fliers, M. Korbonits, and J.A. Romijn, Eds. 2014, Elsevier. p. 151-166.","DOI":"10.1016\/B978-0-444-59602-4.00011-3"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0058","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2010.2.FOCUS09318","article-title":"Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships","volume":"28","author":"Gabriel","year":"2010","journal-title":"Neurosurg Focus FOC"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0059","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00701-020-04265-1","article-title":"Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section","volume":"162","author":"Cossu","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"issue":"1 Suppl","key":"10.1016\/j.lpm.2021.104078_bib0060","first-page":"3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0061","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-11-0158","article-title":"Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up","volume":"165","author":"M\u00fcller","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2021.104078_bib0062","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/j.wneu.2017.11.012","article-title":"Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus","volume":"110","author":"Prieto","year":"2018","journal-title":"World Neurosurg"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0063","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3174\/ajnr.A5361","article-title":"Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images","volume":"38","author":"Prieto","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2021.104078_bib0064","series-title":"Adult craniopharyngiomas: differences and lessons from paediatrics","first-page":"99","article-title":"Cranial surgery for adult craniopharyngiomas: techniques and indications","author":"Jouanneau","year":"2020"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0065","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2010.1.FOCUS09307","article-title":"Craniopharyngioma: a comparison of tumor control with various treatment strategies","volume":"28","author":"Isaac","year":"2010","journal-title":"Neurosurg Focus FOC"},{"key":"10.1016\/j.lpm.2021.104078_bib0066","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jss.2018.01.029","article-title":"Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis","volume":"226","author":"Wang","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.lpm.2021.104078_bib0067","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1016\/j.wneu.2019.03.239","article-title":"Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis","volume":"127","author":"Akinduro","year":"2019","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0068","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-17-0044","article-title":"Very long-term sequelae of craniopharyngioma","volume":"176","author":"Wijnen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.lpm.2021.104078_bib0069","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jocn.2011.09.033","article-title":"Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas","volume":"19","author":"Lee","year":"2012","journal-title":"J Clin Neurosci"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11060-010-0265-y","article-title":"Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma","volume":"101","author":"Sughrue","year":"2011","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0071","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0034-1368785","article-title":"Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000\/2007","volume":"226","author":"Hoffmann","year":"2014","journal-title":"Klin Padiatr"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0072","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00381-012-1926-2","article-title":"A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma","volume":"29","author":"Clark","year":"2013","journal-title":"Child's Nervous Syst"},{"issue":"18","key":"10.1016\/j.lpm.2021.104078_bib0073","first-page":"321","article-title":"The postopera tive quality of life in children and adolescents with craniopharyngioma","volume":"116","author":"Eveslage","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0074","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104078_bib0075","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.1016\/j.wneu.2019.07.217","article-title":"Ommaya reservoir system for the treatment of cystic craniopharyngiomas: surgical results in a series of 11 adult patients and review of the literature","volume":"132","author":"Frio","year":"2019","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0076","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/02688697.2012.741732","article-title":"Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study","volume":"27","author":"Moussa","year":"2013","journal-title":"Br J Neurosurg"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0077","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2010.1.FOCUS09315","article-title":"Intracystic treatments for craniopharyngioma","volume":"28","author":"Steinbok","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"10","key":"10.1016\/j.lpm.2021.104078_bib0078","first-page":"683","article-title":"[Intracystic therapy of bleomycin for craniopharyngioma\u2013effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author's transl)]","volume":"2","author":"Kubo","year":"1974","journal-title":"No Shinkei Geka"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0079","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3171\/jns.1985.62.1.0120","article-title":"Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children","volume":"62","author":"Takahashi","year":"1985","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.lpm.2021.104078_bib0080","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/cncr.22633","article-title":"Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience","volume":"109","author":"Hukin","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.lpm.2021.104078_bib0081","article-title":"Intracystic bleomycin for cystic craniopharyngiomas in children","author":"Zhang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2021.104078_bib0082","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2012.00039","article-title":"Intracystic therapies for cystic craniopharyngioma in childhood","volume":"3","author":"Bartels","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0083","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2010.1.FOCUS09310","article-title":"Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases","volume":"28","author":"Cavalheiro","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"8-9","key":"10.1016\/j.lpm.2021.104078_bib0084","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00381-005-1226-1","article-title":"Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma","volume":"21","author":"Cavalheiro","year":"2005","journal-title":"Child's Nervous Syst"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/S0004-282X2011000100011","article-title":"Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon","volume":"69","author":"Dastoli","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"10.1016\/j.lpm.2021.104078_bib0086","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/neuonc\/nox056","article-title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN","volume":"19","author":"Kilday","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0087","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-016-2342-3","article-title":"Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database","volume":"132","author":"Rao","year":"2017","journal-title":"J Neurooncol"},{"issue":"9-10","key":"10.1016\/j.lpm.2021.104078_bib0088","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1159\/000506902","article-title":"Radiotherapy of parasellar tumours","volume":"110","author":"Albano","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0089","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0360-3016(03)01570-0","article-title":"Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults","volume":"58","author":"Stripp","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11102-012-0429-1","article-title":"Radiotherapy for craniopharyngioma","volume":"16","author":"Aggarwal","year":"2013","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0091","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/2016.9.FOCUS16298","article-title":"A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications","volume":"41","author":"Lamiman","year":"2016","journal-title":"Neurosurg Focus"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0092","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-012-0900-x","article-title":"Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation","volume":"109","author":"Shi","year":"2012","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0093","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11060-020-03432-9","article-title":"Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study","volume":"147","author":"Rutenberg","year":"2020","journal-title":"J Neurooncol"},{"issue":"121 Suppl","key":"10.1016\/j.lpm.2021.104078_bib0094","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3171\/2014.8.GKS141411","article-title":"Gamma Knife surgery for craniopharyngioma: report on a 20-year experience","author":"Lee","year":"2014","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nec.2006.02.001","article-title":"Role of radiation therapy and radiosurgery in the management of craniopharyngiomas","volume":"17","author":"Suh","year":"2006","journal-title":"Neurosurg Clin"},{"key":"10.1016\/j.lpm.2021.104078_bib0096","series-title":"Adult craniopharyngiomas: differences and lessons from paediatrics","first-page":"119","article-title":"Definitive radiotherapy in adult population craniopharyngiomas","author":"Feuvret","year":"2020"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0097","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11102-018-0903-5","article-title":"Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma","volume":"21","author":"Losa","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0098","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.radonc.2006.11.005","article-title":"Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas","volume":"82","author":"Minniti","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lpm.2021.104078_bib0099","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1748-717X-9-203","article-title":"Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects","volume":"9","author":"Harrabi","year":"2014","journal-title":"Radiat Oncol"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0100","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/cncr.22703","article-title":"Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy","volume":"109","author":"Combs","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.21530","article-title":"Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function","volume":"51","author":"Merchant","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10143-009-0186-4","article-title":"The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma","volume":"32","author":"Minniti","year":"2009","journal-title":"Neurosurg Rev"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3171\/jns.2000.92.2.0255","article-title":"Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas","volume":"92","author":"Jakacki","year":"2000","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0104","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3171\/2012.9.PEDS12225","article-title":"Pegylated interferon-\u03b1-2b for children with recurrent craniopharyngioma","volume":"10","author":"Yeung","year":"2012","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0105","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/neuonc\/noaa119","article-title":"Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a pediatric brain tumor consortium report","volume":"22","author":"Goldman","year":"2020","journal-title":"Neuro-oncol"},{"issue":"26","key":"10.1016\/j.lpm.2021.104078_bib0106","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.2013.49.8691","article-title":"Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma","volume":"31","author":"Ascierto","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11102-015-0663-4","article-title":"Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor","volume":"19","author":"Aylwin","year":"2016","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0108","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv310","article-title":"Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy","volume":"108","author":"Brastianos","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0109","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00701-017-3311-0","article-title":"Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy","volume":"159","author":"Rostami","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/cns-2016-0034","article-title":"BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors","volume":"6","author":"Roque","year":"2017","journal-title":"CNS Oncol"},{"key":"10.1016\/j.lpm.2021.104078_bib0111","first-page":"1","article-title":"Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report","author":"Himes","year":"2018","journal-title":"J Neurosurg"},{"issue":"57","key":"10.1016\/j.lpm.2021.104078_bib0112","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.18632\/oncotarget.27203","article-title":"Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report","volume":"10","author":"Rao","year":"2019","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.lpm.2021.104078_bib0113","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.6004\/jnccn.2020.7624","article-title":"Successful use of BRAF\/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma","volume":"18","author":"Khaddour","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0114","first-page":"vdaa141","article-title":"Medical debulking with BRAF\/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma","volume":"2","author":"Di Stefano","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"17","key":"10.1016\/j.lpm.2021.104078_bib0115","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.32197","article-title":"Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations","volume":"125","author":"Juratli","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0116","doi-asserted-by":"crossref","first-page":"e28753","DOI":"10.1002\/pbc.28753","article-title":"Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma","volume":"68","author":"Patel","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.lpm.2021.104078_bib0117","unstructured":"Vemurafenib and cobimetinib in treating patients with BRAF V600E mutation positive craniopharyngioma. https:\/\/ClinicalTrials.gov\/show\/NCT03224767."},{"key":"10.1016\/j.lpm.2021.104078_bib0118","unstructured":"Tocilizumab in children with ACP. https:\/\/ClinicalTrials.gov\/show\/NCT03970226."},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0119","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","article-title":"GH replacement does not increase the risk of recurrence in patients with craniopharyngioma","volume":"64","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2021.104078_bib0121","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.wneu.2017.09.164","article-title":"Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: a meta-analysis","volume":"109","author":"Alotaibi","year":"2018","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0122","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-18-0505","article-title":"Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German craniopharyngioma registry (HIT-Endo)","volume":"179","author":"Boekhoff","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0123","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1210\/jc.2004-0667","article-title":"Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer international growth database)","volume":"89","author":"Geffner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0124","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/EJE-13-0280","article-title":"Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction","volume":"169","author":"Yuen","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12020-017-1489-9","article-title":"Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007","volume":"59","author":"Heinks","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0126","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0127","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.2017-01542","article-title":"Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement","volume":"103","author":"Yuen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.lpm.2021.104078_bib0128","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in Adults","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.20945\/2359-3997000000189","article-title":"Personalized approach to growth hormone replacement in adults","volume":"63","author":"van Bunderen","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-012-0806-7","article-title":"The superiority of conservative resection and adjuvant radiation for craniopharyngiomas","volume":"108","author":"Schoenfeld","year":"2012","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0131","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2014.01.019","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia cancer agency experience","volume":"88","author":"Lo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0132","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0360-3016(02)02799-2","article-title":"Craniopharyngioma: the St. Jude children's research hospital experience 1984-2001","volume":"53","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0133","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2020.05.009","article-title":"Management of hypothalamic obesity","volume":"49","author":"M\u00fcller","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.lpm.2021.104078_bib0134","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","article-title":"Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes","volume":"17","author":"Sterkenburg","year":"2015","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijpo.12076","article-title":"Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumours","volume":"11","author":"Haliloglu","year":"2016","journal-title":"Pediatr Obes"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0136","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2013German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"M\u00fcller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-09-0449","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy","volume":"161","author":"Holmer","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0138","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00381-004-1124-y","article-title":"Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma","volume":"21","author":"M\u00fcller","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"10.1016\/j.lpm.2021.104078_bib0139","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/jcm4091774","article-title":"Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention","volume":"4","author":"Roth","year":"2015","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0140","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/jc.2009-2003","article-title":"Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls","volume":"95","author":"O'Gorman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-17-0387","article-title":"The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0707","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0143","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review","volume":"40","author":"van Iersel","year":"2018","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0144","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000496564","article-title":"Hypothalamic obesity: prologue and promise","volume":"91","author":"Abuzzahab","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2010.80","article-title":"Appetite-regulating hormone changes in patients with craniopharyngioma","volume":"19","author":"Roth","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diab.45.5.699","article-title":"Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro","volume":"45","author":"Kolaczynski","year":"1996","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0147","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0148","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/oby.21493","article-title":"A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity","volume":"24","author":"Lomenick","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0149","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-12-0997","article-title":"GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases","volume":"168","author":"Zoicas","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.endinu.2016.10.006","article-title":"Hypothalamic obesity after craniopharyngioma surgery: treatment with a long acting glucagon like peptide 1 derivated","volume":"64","author":"Castro-Dufourny","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0151","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1-2","key":"10.1016\/j.lpm.2021.104078_bib0152","first-page":"45","article-title":"Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience","volume":"28","author":"Kalina","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2021.104078_bib0153","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2169\/internalmedicine.44.832","article-title":"Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin","volume":"44","author":"Igaki","year":"2005","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.lpm.2021.104078_bib0154","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archpedi.156.9.887","article-title":"The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma","volume":"156","author":"Mason","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/JPEM.2006.19.2.129","article-title":"Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury","volume":"19","author":"Ismail","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104078_bib0156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2011.00078","article-title":"Effects of methylphenidate on weight gain and food intake in hypothalamic obesity","volume":"2","author":"Elfers","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0157","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1016\/j.lpm.2021.104078_bib0158","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/jpem-2014-0337","article-title":"Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity","volume":"28","author":"van Santen","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0159","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/meta.2002.35591","article-title":"Triiodothyronine supplementation for hypothalamic obesity","volume":"51","author":"Fernandes","year":"2002","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jc.2017-02080","article-title":"Oxytocin and naltrexone successfully treat hypothalamic obesity in a boy post-craniopharyngioma resection","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lpm.2021.104078_bib0161","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2012-4184","article-title":"Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis","volume":"98","author":"Bretault","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0162","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ijo.2016.195","article-title":"Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up","volume":"41","author":"Wijnen","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0163","doi-asserted-by":"crossref","first-page":"e76562","DOI":"10.1371\/journal.pone.0076562","article-title":"Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review","volume":"8","author":"Zada","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0164","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-015-1885-z","article-title":"A systematic review of cognitive performance in patients with childhood craniopharyngioma","volume":"125","author":"\u00d6zyurt","year":"2015","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00381-010-1301-0","article-title":"Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma","volume":"27","author":"Ondruch","year":"2011","journal-title":"Child's Nervous Syst"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0166","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.2004.tb00476.x","article-title":"Outcome of craniopharyngioma in children: long-term complications and quality of life","volume":"46","author":"Poretti","year":"2004","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0167","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-018-2936-z","article-title":"Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma","volume":"140","author":"Mehren","year":"2018","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.lpm.2021.104078_bib0168","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence1","volume":"83","author":"B\u00fclow","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104078_bib0169","series-title":"Adult craniopharyngiomas: differences and lessons from paediatrics","first-page":"157","article-title":"Disease and treatment-related hypothalamic alterations in craniopharyngioma: clinical presentation, prognostic impact, and implications for treatment strategies","author":"M\u00fcller","year":"2020"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0707","article-title":"Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study","volume":"178","author":"Wijnen","year":"2018","journal-title":"J Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104078_bib0171","first-page":"671","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.Eur","volume":"161","author":"Holmer","year":"2009","journal-title":"J Endocrinol"},{"issue":"9254","key":"10.1016\/j.lpm.2021.104078_bib0172","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lpm.2021.104078_bib0173","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0174","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12020-018-1830-y","article-title":"Excess mortality after craniopharyngioma treatment: are we making progress?","volume":"64","author":"Qiao","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.lpm.2021.104078_bib0176","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.lpm.2021.104078_bib0177","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01401137","article-title":"Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases","volume":"124","author":"Szeifert","year":"1993","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"10.1016\/j.lpm.2021.104078_bib0178","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","article-title":"Mortality in adults with hypopituitarism: a systematic review and meta-analysis","volume":"56","author":"Jasim","year":"2017","journal-title":"Endocrine"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:09:21Z","timestamp":1760105361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":178,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0755498221000178"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104078","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Craniopharyngiomas","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104078"}}